The physiological and pharmacological significance of cardiovascular T-type, voltage-gated calcium channels

American Journal of Hypertension

Volumn 11, Issue 4 SUPPL. 2, 1998, Pages 80S-87S

  Triggle, David J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Calcium; Calcium channel blocker; Mibefradil; T type channel

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; INDOLIZINE DERIVATIVE; MIBEFRADIL; NIFEDIPINE; SR 33357; UNCLASSIFIED DRUG; VERAPAMIL;

BLOOD VESSEL TONE; CALCIUM TRANSPORT; CARDIOVASCULAR RESPONSE; CELL COMPARTMENTALIZATION; DRUG EFFECT; HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BENZIMIDAZOLES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CARDIOVASCULAR SYSTEM; ELECTROPHYSIOLOGY; HUMANS; ION CHANNEL GATING; MIBEFRADIL; TETRAHYDRONAPHTHALENES;

EID: 0031800949     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00004-1     Document Type: Article

References (44)

1. Katz A: Calcium channel diversity in the cardiovascular system. J Am Coll Cardiol 1996;28:522-529.
2. Opie L: Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use. Prog Cardiovasc Dis 1996;38:273-290.
3. Hess P: Calcium channels in vertebrate cells. Annu Rev Neurosci 1990;13:337-356.
4. Triggle D: Pharmacologic and therapeutic differences among calcium channel blockers: profile of mibefradil, a new calcium antagonist. Am J Cardiol 1996;78:7-12.
5. Braunwald E: Mechanism of action of calcium-channel-blocking agents. N Engl J Med 1982;307:1618-1627.
6. Triggle D: Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Clevel Clin J Med 1992;59:617-627.
7. Bean B: Classes of calcium channels in vertebrate cells. Annu Rev Physiol 1989;51:367-384.
8. Bean B: Two kinds of calcium channels in canine atrial cells: differences in kinetics, selectivity, and pharmacology. J Gen Physiol 1985;86:1-30.
9. Hagiwara N, Irisawa H, Kameyama M: Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 1988;395: 233-253.
10. Xu X, Best P: Postnatal changes in T-type calcium current density in rat atrial myocytes. J Physiol 1992;454: 657-672.
11. Fedulova S, Kostyuk P, Veselovsky N: Two types of calcium channels in the somatic membrane of newborn rat dorsal root ganglion neurones. J Physiol 1985; 359:431-446.
12. Beam K, Knudson C: Calcium currents in embryonic and neonatal mammalian skeletal muscle. J Gen Physiol 1988;91:781-798.
13. Ertel E, Warren V, Adams M, et al: Type III omega-agatoxins: a family of probes for similar binding sites on L- and N-type calcium channels. Biochemistry 1994; 33:5098-5108.
14. Argibay J, Fischmeister R, Hartzell H: Inactivation, reactivation and pacing dependence of calcium current in frog cardiocytes: correlation with current density. J Physiol (Lond) 1988;401:201-226.
15. Beuckelmann D, Näbauer M, Erdmann E: Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol 1991;23:929-937.
16. Hirano Y, Fozzard H, January C: Characteristics of L-and T-type currents in canine cardiac Purkinje cells. Am J Physiol 1989;256:H1478-H1492.
17. 2+ currents in single canine Purkinje cells. Circ Res 1989;65:1735-1750.
18. 2+ current in smooth muscle cells by diacylglycerol and acetylcholine. FASEB J 1988;2:2497-2504.
19. Smirnov S, Zholos A, Shuba M: Potential-dependent inward currents in single isolated smooth muscle cells of the rat ileum. J Physiol (Lond) 1992;454:549-571.
20. Akaike N, Kanaide H, Kuga T, et al: Low-voltage-activated calcium current in rat aorta smooth muscle cells in primary culture. J Physiol 1989;416:141-160.
21. Ganitkevich V, Isenberg G: Contribution of two types of calcium channels to membrane conductance of single myocytes from guinea-pig coronary artery. J Physiol 1990;426:19-42.
22. Armstrong C, Matteson D: Two distinct populations of calcium channels in a clonal line of pituitary cells. Science 1985;227:65-67.
23. Cohen C, McCarthy R: Differential effects of dihydropyridines on two populations of Ca channels in anterior pituitary cells (abst). Biophys J 1985;47:513.
24. + and angiotensin II increase T-type Ca channel current. Proc Nat Acad Sci USA 1988;85:2412-2416.
25. McCarthy R, Isales C, Bollag W, et al: Atrial natriuretic peptide differentially modulates T- and L-type calcium channels. Am J Physiol 1990;258:F473-F478.
26. Xu X, Best P: Increase in T-type calcium current in atrial myocytes from adult rats with growth hormone-secreting tumors. Proc Natl Acad Sci USA 1990;87:4655-4659.
27. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 1993;73:777-782.
28. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res 1994;75:149-155.
29. Furukawa T, Ito H, Nitta J, et al: Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocytes. Circ Res 1992; 71:1242-1253.
30. 2+ currents in cardiac cells. J Cardiovasc Pharmacol 1995;26(suppl 3):S293-S296.
31. Yokokawa K, Kohno M, Murakawa K, et al: Effect of endothelin-1 on cytosolic calcium ions in cultured human endothelial cells. J Hypertens 1990;8:843-849.
32. Weber K, Brilla C: Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-1865.
33. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
34. Ito H, Hirata Y, Hiroe M, et al: Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991;69:209-215.
35. A receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 1994; 89:2198-2203.
36. 2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts. Am J Physiol 1993;265:C1239-C1246.
37. Estacion M, Mordan L: Expression of voltage-gated calcium channels correlates with PDGF-stimulated calcium influx and depends upon cell density in C3H 10T1/2 mouse fibroblasts. Cell Calcium 1993;14:161-171.
38. Lüscher T, Clozel J-P, Noll G: Pharmacology of the calcium antagonist mibefradil. J Hypertens 1997; 15(suppl 3):S11-S18.
39. 2+ channel blocker with potent vasodilator but weak inotropic action. J Cardiovasc Pharmacol 1989;13:754-759.
40. 2+ channel in cardiac tissue. Eur J Pharmacol 1995;290:155-158.
41. 2+ channels by Ro 40-5907. Circ Res 1994; 75: 144-148.
42. ++ channels. J Pharmacol Exp Ther 1994; 271:1483-1488.
43. Schmitt R, Clozel J-P, Iberg N, Buhler F: Mibefradil prevents neointima formation after vascular injury in rats: possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler Thromb Vasc Biol 1995;15:1161-1165.
44. Tsang C-M, Presser F, Morad M: Amiloride selectively blocks the low threshold (T) calcium channel. Science 1988;240:213-215.